Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation

As a part of our project directed at the search of new chemotherapeutic agents against American trypanosomiasis (Chagas' disease), several drugs possessing the 4-phenoxyphenoxy skeleton and other closely related structures employing the thiocyanate moiety as polar end group were designed, synth...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Szajnman, S.H
Otros Autores: Yan, W., Bailey, B.N, Docampo, R., Elhalem, E., Rodriguez, J.B
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2000
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 15837caa a22013577a 4500
001 PAPER-2350
003 AR-BaUEN
005 20230518203144.0
008 190411s2000 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0034030531 
024 7 |2 cas  |a Indicators and Reagents; Thiocyanates; Trypanocidal Agents 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a JMCMA 
100 1 |a Szajnman, S.H. 
245 1 0 |a Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation 
260 |c 2000 
270 1 0 |m Rodriguez, J.B.; Departamento de Quimica Organica, Fac. de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, RA-1428 Buenos Aires, Argentina; email: JBR@qo.fcen.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Control of chagas' disease (1991) WHO Technical Report Series No. 811, 811. , World Health Organization: Geneva 
504 |a Moncayo, A., (1993) Eleventh Programme Report of the UNPD/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR), pp. 67-75. , World Health Organization: Geneva 
504 |a Brener, Z., Biology of Trypanosoma cruzi (1973) Annu. Rev. Microbiol., 27, pp. 347-382 
504 |a De Souza, W., Cell biology of Trypanosoma cruzi (1984) Int. Rev. Cytol., 86, pp. 197-283 
504 |a De Castro, S.L., The challenge of Chagas' disease chemotherapy: An update of drugs assayed against Trypanosoma cruzi (1993) Acta Trop., 53, pp. 83-98 
504 |a Rodriguez, J.B., Gros, E.G., Recent developments in the control of Trypanosoma cruzi, the causative agent for Chagas' disease (1995) Curr. Med. Chem., 2, pp. 723-749 
504 |a Taylor, M.B., Gutteridge, W.E., Trypanosoma cruzi: Subcellular distribution of glycolytic and some related enzymes of epimastigotes (1987) Exp. Parasitol., 63, pp. 84-97 
504 |a Fairlamb, A.H., Cerami, A., Metabolism and functions of trypanothione in the Kinetoplastida (1992) Annu. Rev. Microbiol., 46, pp. 695-729 
504 |a Aronov, A.M., Verlinde, C.L.M.J., Hol, W.G.J., Gelb, M.H., Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design (1998) J. Med. Chem., 41, pp. 4790-4799 
504 |a Urbina, J.A., Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites (1997) Parasitology, 114, pp. 91-99 
504 |a Yokoyama, K., Trobridge, P., Buckner, F.S., Scholten, J., Stuart, K.D., Van Voorhis, W.C., Gelb, M.H., The effects of protein farnesyltransferase inhibitors on trypanosomatids: Inhibition of protein farnesylation and cell growth (1998) Mol. Biochem. Parasitol., 94, pp. 87-97 
504 |a Marr, J.J., Docampo, R., Chemotherapy for Chagas' disease: A perspective of current therapy and considerations for future research (1986) Rev. Infect. Dis., 8, pp. 884-903 
504 |a Gutteridge, W.E., Existing chemotherapy and its limitations (1985) Br. Med. Bull., 41, pp. 162-168 
504 |a Neal, R.A., Van Bueren, J., Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro (1988) Trans. R. Soc. Trop. Med. Hyg., 82, pp. 709-714 
504 |a Filardi, L.S., Brener, Z., Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease (1987) Trans. R. Soc. Trop. Med. Hyg., 81, pp. 755-759 
504 |a Murta, S.M., Romanha, A.J., In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole (1998) Parasitology, 116, pp. 165-171 
504 |a Nozaki, T., Engel, J., Dvorak, J., Cellular and molecular biological analyses of nifurtimox resistance in Trypanosoma cruzi (1996) Am. J. Trop. Med. Hyg., 55, pp. 111-117 
504 |a Moncayo, A., Chagas' disease: Epidemiology and prospects for interruption of transmission in the Americas (1992) World Health Stat Q., 45, pp. 276-279 
504 |a Kirchhoff, L.V., American Trypanosomiasis (Chagas' disease). A tropical disease now in the United States (1993) N. Engl. J. Med., 329, pp. 639-644 
504 |a Galel, S.A., Kirchhoff, L.V., Risk factors for Trypanosoma cruzi infection in California blood donors (1996) Transfusion, 36, pp. 227-231 
504 |a Shulman, I.A., Appleman, M.D., Saxena, S., Hiti, A.L., Kirchhoff, L.V., Specific antibodies to Trypanosoma cruzi among blood donors in Los Angeles, California (1997) Transfusion, 37, pp. 727-731 
504 |a Nussenzweig, V., Sonntag, R., Biancalana, A., Pedreira De Fleitas, J.L., Amato Neto, V., Kloetzel, J., Acão de corantes trifenil-metanicos sobre o Trypanosoma cruzi in vitro. Emprêgo de violeta de genciana na profilaxia da transmissão da moléstia de Chagas por transfusão de sangue (1953) Hospital (Rio de Janeiro), 44, pp. 731-744 
504 |a Docampo, R., Moreno, S.N.J., Biochemical toxicology of anti-parasitic compounds used in the chemotherapy and chemoprophylaxis of American Trypanosomiaisis (Chagas' disease) (1985) Rev. Biochem. Toxicol., 7, pp. 159-204 
504 |a Docampo, R., Schmuñis, G.A., Sterol biosynthesis inhibitors: Potential chemotherapeutics against Chagas disease (1997) Parasitol. Today, 13, pp. 129-130 
504 |a Urbina, J.A., Payares, G., Molina, J., Sanoja, C., Liendo, A., Lazardi, K., Piras, M.M., Ryley, J.F., Cure of short- and long-term experimental Chagas' disease using D0870 (1996) Science, 273, pp. 969-971 
504 |a Liendo, A., Lazardi, K., Urbina, J.A., In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi (1998) J. Antimicrob. Chemother., 41, pp. 197-205 
504 |a Urbina, J.A., Payares, G., Contreras, L.M., Liendo, A., Sanoja, C., Molina, J., Piras, M., Loebenberg, D., Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo studies (1998) Antimicrob. Agents Chemother., 42, pp. 1771-1777 
504 |a Docampo, R., Moreno, S.N.J., Turrens, J.F., Katzin, A.M., Gonzalez-Cappa, S.M., Stoppani, A.O.M., Biochemical and ultrastructural alterations produced by miconazole and econazole in Trypanosoma cruzi (1981) Mol. Biochem. Parasitol., 3, pp. 169-180 
504 |a Urbina, J.A., Chemotherapy of Chagas' disease: The how and the why (1999) J. Mol. Med., 77, pp. 332-338 
504 |a Masner, P., Dorn, S., Vogel, W., Kaelin, M., Graf, O., Guenthart, E., Types of response of insects to a new insect growth regulators and to a proven standards (1981) Pr. Nauk. Inst. Chem. Org. Fiz. Politech. Wroclaw, 22, pp. 809-818 
504 |a Rodriguez, J.B., Gros, E.G., Stoka, A.M., Synthesis and activity of juvenile hormone analogues (JHA) for Trypanosoma cruzi (1991) Biomed. Chem. Lett., 1, pp. 679-682 
504 |a Cinque, G.M., Szajnman, S.H., Zhong, L., Docampo, R., Rodriguez, J.B., Gros, E.G., Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi (1998) J. Med. Chem., 41, pp. 1540-1554 
504 |a Schvartzapel, A.J., Zhong, L., Docampo, R., Rodriguez, J.B., Gros, E.G., Design, synthesis and biological evaluation of new growth inhibitors of Trypanosoma cruzi (Epimastigotes) (1997) J. Med. Chem., 40, pp. 2314-2322 
504 |a Schvartzapel, A.J., Fichera, L., Esteva, M., Rodriguez, J.B., Gros, E.G., Design, synthesis, and anti-Trypanosoma cruzi evaluation of a new class of cell growth inhibitors structurally related to Fenoxycarb (1995) Helv. Chim. Acta, 78, pp. 1207-1214 
504 |a Stoka, A.M., Rivas, C., Segura, E., Rodriguez, J.B., Gros, E.G., Biological activity of synthetic juvenile hormone analogues for Trypanosoma cruzi (1990) Z. Naturforsch. B, 45, pp. 96-98 
504 |a Perlawagora-Szumlewicz, A., Petana, W.P., Figueiredo, M.J., The evaluation of host efficiency and vector potential of laboratory juvenilized vector of Chagas' disease. I - Effects of developmental changes induced by juvenile hormone analogues in Pantrongylus megistus (Hemiptera -Reduviidae) on the susceptibility of insects to gut infection with Trypanosoma cruzi (1975) Rev. Inst. Med. Trop., 17, pp. 97-102 
504 |a Rodriguez, J.B., Gros, E.G., Stoka, A.M., Synthesis and activity of juvenile hormone analogues (JHA) (1988) Z. Naturforsch, 43 B, pp. 1038-1042 
504 |a Rodriguez, J.B., Gros, E.G., Stoka, A.M., Synthesis and activity of juvenile hormone analogues (JHA). Part II (1989) Z. Naturforsch., 44 B, pp. 983-987 
504 |a Kramer, S.J., Law, J.H., Synthesis and transport of juvenile hormones in insects (1980) Acc. Chem. Res., 13, pp. 297-303 
504 |a Urbina, J.A., Unpublished information; Rodriguez, J.B., Docampo, R., Gros, E.G., Sulfur-containing derivatives structurally related to fenoxycarb are potent growth inhibitors against the intracellular form of Trypanosoma cruzi (2000) Int. J. Antimicrob. Agents, 13, pp. 215-218 
504 |a Rodriguez, J.B., Zhong, L., Docampo, R., Gros, E.G., Biological evaluation of two potent inhibitors of Trypanosoma cruzi epimastigotes against the intracellular form of the parasite (1996) BioMed. Chem. Lett., 6, pp. 2783-2786 
504 |a Fichera, L., Esteva, M., Wimmer, Z., Rodriguez, J.B., Gros, E.G., Effects of juvenile hormone analogues (JHA) on the development of Trypanosoma cruzi (1995) Z. Naturforsch. C, 50, pp. 578-580 
504 |a Rundel, W., Notiz über die darstellung tert-butylierter tiophenole, diphenyl disulfide und thiantrene (1968) Chem. Ber., 101, pp. 2956-2962 
504 |a Johnstone, R.A.W., Rose, M.E., A rapid, simple, and mild procedure for alkylation of phenols, alcohols, amides and acids (1979) Tetrahedron, 75, pp. 2169-2172 
504 |a Miyashita, N., Yoshikoshi, A., Grieco, P.A., Pyridinium p-toluensulfonate. A mild and efficient catalyst for the tetrahydropyranylation of alcohols (1977) J. Org. Chem., 42, pp. 3772-3774 
504 |a Witczack, Z.J., Monosaccharide isothiocyanates and thiocyanates: Synthesis, chemistry, and preparative applications (1986) Adv. Carbohydr. Chem. Biochem., 44, pp. 91-145 
504 |a Appel, R., Tertiary phosphane/tetrachloromethane, a versatile reagent for chlorination, dehydration, and phosphorus-nitrogen linking (1975) Angew. Chem., Int. Ed. Engl., 14, pp. 801-812 
504 |a Slage, J.D., Huang, S.K., Franzus, B., Mechanism of the triphenylphosphine-tetrachloromethane-alcohol reaction: Pericyclic or clustered ion pairs? (1981) J. Org. Chem., 46, pp. 3526-3530 
504 |a Weingarten, H., Ullmann condensation (1964) J. Org. Chem., 29, pp. 977-978 
504 |a Gallo-Rodriguez, C., Ji, X.-D., Melman, N., Siegman, B.D., Sanders, L.H., Orlina, J., Fischer, B., Jacabson, K.A., Structure-activity relationships of N6-benzyladenosine-5′-uronamides as A3-selective adenosine agonists (1994) J. Med. Chem., 37, pp. 636-646 
504 |a Dimroth, K., Berndt, A., Perst, H., Reichardt, C., 2,4,6-Triphenylphenoxyl (1973) Organic Synthesis, 5, pp. 1130-1134. , Wiley & Sons: New York, Collect 
504 |a Newman, N.S., Boden, H., 2,4,5,7-Tetranitrofluorenone (9-fluorenone, 2,4,5,7-tetranitro-) (1973) Organic Synthesis, 5, pp. 1029-1130. , Wiley & Sons: New York, Collect 
504 |a Yan, W., Moreno, S.N., A method to assess invasion and intracellular replication of Trypanosoma cruzi based on differential uracil incorporation (1998) J. Immunol. Methods, 220, pp. 123-128 
520 3 |a As a part of our project directed at the search of new chemotherapeutic agents against American trypanosomiasis (Chagas' disease), several drugs possessing the 4-phenoxyphenoxy skeleton and other closely related structures employing the thiocyanate moiety as polar end group were designed, synthesized, and evaluated as antiproliferative agents against Trypanosoma cruzi, the parasite responsible for this disease. These thiocyanate analogues were envisioned bearing in mind the potent activity shown by 4- phenoxyphenoxyethyl thiocyanate (compound 8) taken as lead drug. This compound had previously proved to be an extremely active growth inhibitor against T. cruzi with IC50 values ranging from the very low micromolar level in epimastigotes to the low nanomolar level in the intracellular form of the parasite. Of the designed compounds, the ethyl thiocyanate drugs connected to nonpolar skeletons, namely, arylthio, 2,4-dichlorophenoxy, ortho-substituted aryloxy, and 2-methyl-4-phenoxyphenoxy (compounds 15, 34, 47, 52, 72, respectively), were shown to be very potent antireplicative agents against T. cruzi. On the other hand, conformationally restricted analogues as well as branched derivatives at the aliphatic side chain were shown to be moderately active against T. cruzi growth. The biological activity of drugs bearing the thiocyanate group correlated quite well with the activity exhibited by their normal precursors, the tetrahydropyranyl ether derivatives, when bonded to the same nonpolar skeleton. Compounds having the tetrahydropyranyl moiety as polar end were proportionally much less active than sulfur-containing derivatives in all cases. Drugs 47 and 72 also resulted to be very active against the amastigote form of the parasite growing in myoblasts; however, they were slightly less active than the lead drug 8. On the other hand, compounds 34 and 52 were almost devoid of activity against myoblasts. Surprisingly, the dithio derivative 15 was toxic for myoblasts.  |l eng 
593 |a Depto. de Quim. Orgánica, Fac. de Ciencias Exactas y Naturales, Universidad de Buenos Aires, RA-1428 Buenos Aires, Argentina 
593 |a Laboratory of Molecular Parasitology, Department of Pathobiology, Univ. Illinois at Urbana-Champaign, 2001 South Lincoln Avenue, Urbana, IL 61802, United States 
690 1 0 |a 2 (4 PHENOXYPHENYLTHIO)ETHYL THIOCYANIC ACID 
690 1 0 |a 2 BROMO 4 PHENOXYPHENOXYETHYL THIOCYANIC ACID 
690 1 0 |a 2 IODO 4 PHENOXYPHENOXYETHYL 4 THIOCYANIC ACID 
690 1 0 |a 2,4 DICHLOROPHENOXYETHYL THIOCYANIC ACID 
690 1 0 |a 4 (2 METHYLPHENOXY)PHENOXYETHYL THIOCYANIC ACID 
690 1 0 |a ANTIPROTOZOAL AGENT 
690 1 0 |a THIOCYANIC ACID DERIVATIVE 
690 1 0 |a UNCLASSIFIED DRUG 
690 1 0 |a ANTIPROTOZOAL ACTIVITY 
690 1 0 |a ARTICLE 
690 1 0 |a CHAGAS DISEASE 
690 1 0 |a DRUG POTENCY 
690 1 0 |a DRUG SYNTHESIS 
690 1 0 |a GROWTH INHIBITION 
690 1 0 |a NONHUMAN 
690 1 0 |a TRYPANOSOMA 
690 1 0 |a TRYPANOSOMA CRUZI 
690 1 0 |a TRYPANOSOMIASIS 
690 1 0 |a ANIMALS 
690 1 0 |a CELL DIVISION 
690 1 0 |a DRUG DESIGN 
690 1 0 |a INDICATORS AND REAGENTS 
690 1 0 |a MAGNETIC RESONANCE SPECTROSCOPY 
690 1 0 |a MASS SPECTROMETRY 
690 1 0 |a SPECTROPHOTOMETRY, ULTRAVIOLET 
690 1 0 |a STRUCTURE-ACTIVITY RELATIONSHIP 
690 1 0 |a THIOCYANATES 
690 1 0 |a TRYPANOCIDAL AGENTS 
690 1 0 |a TRYPANOSOMA CRUZI 
700 1 |a Yan, W. 
700 1 |a Bailey, B.N. 
700 1 |a Docampo, R. 
700 1 |a Elhalem, E. 
700 1 |a Rodriguez, J.B. 
773 0 |d 2000  |g v. 43  |h pp. 1826-1840  |k n. 9  |p J. Med. Chem.  |x 00222623  |w (AR-BaUEN)CENRE-686  |t Journal of Medicinal Chemistry 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034030531&doi=10.1021%2fjm9905007&partnerID=40&md5=845c457a4d6297766c8c9f8b002a9105  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1021/jm9905007  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00222623_v43_n9_p1826_Szajnman  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00222623_v43_n9_p1826_Szajnman  |y Registro en la Biblioteca Digital 
961 |a paper_00222623_v43_n9_p1826_Szajnman  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 63303